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We	found	significantly	higher	incidence	of	Toxoplasma gon-
dii	DNA	 in	eye	bank	specimens	 from	Joinville	 in	southern	
Brazil	(13/15,	87%)	than	in	São	Paulo	(3/42,	7%;	p	=	2.1	×	
10E–8).	PCR	DNA	sequence	analysis	was	more	sensitive	
at	locus	NTS2	than	at	locus	B1;	a	high	frequency	of	mixed	
co-infections	was	detected.
Toxoplasma gondii is a protozoan parasite that infects nearly one third of the world’s human population. In-
fection is typically asymptomatic, but life-threatening dis-
ease may develop in immunocompromised patients and 
when the infection is acquired congenitally (1). When 
parasites migrate to the eye, ocular toxoplasmosis (OT) 
can occur; this potentially blinding disease causes a high 
incidence of uveitis worldwide (1). In the United States, 
≈2% of Toxoplasma infections progress to OT, whereas in 
southern Brazil, the proportion can be >18% (1). Factors 
leading to development of OT are poorly understood. In 
most OT studies, the study population is symptomatic per-
sons.  Little is known about OT infection status among a 
random population. We investigated the incidence of OT in 
a random population in Brazil and determined the sensitiv-
ity of 3 PCR diagnostic markers used for detecting parasite 
DNA and genotype. 
The Study
In southern Brazil, incidence of OT ranges from 9.8% to 
22% (2–4). In 1985, as part of a study to determine preva-
lence of toxoplasmic retinochoroidal lesions among a ran-
dom population, 270 archived eyes submitted to the São 
Paulo Eye Bank consecutively were examined for macro-
scopic chorioretinal lesions or histologic evidence of reti-
nochoroiditis (R. Belfort, Jr., unpub. data). Each was from 
a different person (no bilateral specimens were received). 
Eighteen (6.7%) eyes had chorioretinitis and 9 (3.3%) 
possessed cicatrial lesions; total prevalence was 10% 
(27/270). Of these 27 eyes, 8 (3.0%) had mononuclear cells, 
and 1 (0.4%) had acute, inflammatory infiltrate consistent 
with OT (Figure 1). These eyes were no longer available 
for molecular testing.
To determine updated infection prevalence rates, we 
obtained 114 eyes collected during 2009 from eye banks 
in 2 disease-endemic regions of Brazil with different OT 
incidence rates, the south (Joinville, n = 15) and southeast 
(São Paulo, n = 42) (Figure 2). The eyes were collected 
consecutively from deceased persons who donated to eye 
banks, 15 in Joinville and 42 in São Paulo. All eyes were 
from patients who died of natural causes or in an accident 
and who had no history or symptoms of ophthalmologic 
disease. The average age of donors was 54 years (range 
20–76 years); exclusion criteria included a history of lym-
phoma, leukemia, leptospirosis, hepatitis B or C, HIV, 
rabies, or bacteria associated with endocarditis. Matched 
serum samples for each eye were not available. 
We extracted DNA from eyes to ascertain T. gondii 
prevalence and Toxoplasma genotype. Eyes were not ex-
amined macroscopically. Retinal DNA was extracted by 
using a QIAamp DNA Blood Midi Kit (QIAGEN, Valen-
cia, CA, USA). Multilocus PCR DNA sequencing was per-
formed by using B1, NTS2, and GRA7 loci, as described 
(5,6). Positive (type I RH DNA) and negative (water only) 
controls were run alongside each PCR. PCR products were 
treated with ExoSAP-IT (USB Corp., Cleveland, OH, 
USA) before DNA sequencing (RML Genomics, Hamil-
ton, MT, USA).
Specimens from 3 (7.1%) of 42 donors from São 
Paulo tested positive at NTS2 (online Technical Appendix 
Table, http://wwwnc.cdc.gov/EID/article/22/4/15-1192-
Techapp1.pdf), similar to the incidence rate determined 
among the eyes examined macroscopically in 1985 and 
consistent with previously published work (7). Our re-
sults show that no significant change in relative frequency 
of Toxoplasma infection occurred in eyes donated in São 
Paulo over a 25-year period. DNA sequence analysis of the 
3 positive samples identified an archetypal allele shared 
by types II and III strains at NTS2. Only 1 NTS2-positive 
eye (no. 37) was positive at B1 (sensitivity 33% relative 
to NTS2; B1 is a standard diagnostic marker [5]). It pos-
sessed a unique allele (online Technical Appendix Table). 
No samples were PCR positive at the GRA7 marker.
Of the 15 donors from Joinville, 13 (87%) tested posi-
tive for Toxoplasma DNA at NTS2. Six samples possessed 
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type I alleles, 1 had a unique allele sharing phylogenetic 
ancestry with type I, 2 had drifted type II or type III al-
leles, and 4 possessed a mixture of 2 allelic types, indica-
tive of mixed strain co-infection. The detection of 5, 3, 
and 3 distinct and mostly novel alleles at NTS2, B1, and 
GRA7, respectively, argue against the possibility that the 
PCR results were due to a false-negative amplification. A 
high incidence of mixed infection has been observed previ-
ously in Australian marsupials (8), but it is considered rare 
in human infection (9). In contrast, only 6 samples were 
positive at B1 (sensitivity 46% relative to NTS2); 1 sample 
had a type I allele, 4 had a unique allele, and 1 (no. 5) had a 
mixture of 2 different alleles. Three samples were positive 
at GRA7 (sensitivity 23% relative to NTS2); a type I allele, 
and 2 alleles sharing phylogenetic ancestry with type I and 
type III, respectively (online Technical Appendix Table).
Southern Brazil experiences different incidence rates 
and severity of OT, although overall toxoplasmosis preva-
lence rates are similar. Studies in metropolitan São Paulo 
identified Toxoplasma antibodies in samples from pregnant 
patients that ranged from 59% to 65% across 2 decades, 
but no data on frequency of OT was reported (10,11). One 
2004 study showed that ≈10% of the metropolitan Sao Pau-
lo population has OT (7). Seroprevalence in São Jose do 
Rio Preto, another city in São Paulo State, is 74.5%, and 
the incidence of OT in 2009–2010 was 20.3% (2). Sero-
positivity in Erechim, a southern city in Rio Grande do Sul, 
is ≈88%; OT occurs frequently (18%) and is severe (12). 
Conclusions
Our results reveal differences in the ability of parasites to 
infect eyes collected from the general population in dif-
ferent geographic regions of Brazil. The difference in eye 
infection prevalence rates suggests that, although most of 
the São Paulo population is seropositive, only 7% of the 
population harbor Toxoplasma parasites capable of mi-
grating to the eye. However, 87% of eyes from Joinville 
tested positive for parasite DNA (a 1:1 correlation with 
seroprevalence), which may indicate that no apparent bar-
rier to parasite entry into the eye exists in this geographic 
region. Although not all patients bearing parasite infec-
tions in their eyes develop OT, similar to the finding that 
only 30%–50% of AIDS patients experience recrudescent 
disease (13), our results may explain the increased inci-
dence of OT in southern Brazil and help clarify possible 
factors controlling the disease.
Our findings also show that the 110 gene-copy NTS2 
marker proved more sensitive than B1, a marker tradi-
tionally used to detect infection (5). In addition, NTS2 
polymorphisms enabled mixed strain co-infections to be 
detected in the eyes of donor no. 5. Multilocus typing es-
tablished that atypical strains common to Brazil caused 
most eye infections and identified different Toxoplasma 
genotypes circulating between the 2 locations; e.g., strains 
bearing alleles that share phylogenetic ancestry with type I 
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Figure 1.	Representative	retinochoroidal	lesions	depicted	for	3	of	18	archived	eyes	examined	by	optical	microscopy	for	evidence	of	
Toxoplasma gondii infection;	270	single	eyes	were	examined,	each	from	a	different	donor,	obtained	during	1985	and	2009	in	São	Paulo,	
São	Paulo	State,	Brazil.	Original	magnification	(left	to	right):	×20,	×20,	×12.
Figure 2.	Cities	where	retinochoroidal	scars	consistent	with	
Toxoplasma gondii	infection	were	found	on	eyes	donated	to	eye	
banks	in	Brazil	during	1985	and	2009:	São	Paulo,	São	Paulo	(SP)	
State,	and	its	relative	position	in	southern	Brazil	to	Joinville,	Santa	
Catarina	(SC)	State;	522	km	separates	the	2	cities.	
T. gondii	Infection	Rate	for	Retinas,	Brazil
were only identified in Joinville. Previous studies suggest-
ed a link between parasite genotype and development of 
OT (14). Our work using serologic typing has established 
that the parasite genotype is associated with more serious 
congenital and ocular disease among patients in the United 
States and Europe (6,15). Ultimately, to determine whether 
increased eye infection rates in Joinville is dependent on 
parasite genotype, or an associated host genetic risk fac-
tor, prospective sampling should be done on eyes donated 
to eye banks. The serostatus of the donor, whether retinal 
scars are present, and the geographic origin of the donor 
can be recorded to determine factors associated with para-
site infection and whether such donated eyes should be pre-
cluded from transplantation.
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